1-2 of 2
Lindsey Herbein
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase 3 Study Evaluating the Efficacy and Safety of Lenalidomide (Len) Combined with Melphalan and Prednisone Followed by Continuous Lenalidomide Maintenance (MPR-R) in Patients (Pts) ≥ 65 Years (Yrs) with Newly Diagnosed Multiple Myeloma (NDMM): Updated Results for Pts Aged 65–75 Yrs Enrolled in MM-015

Antonio Palumbo, MD, Zdenek Adam, Martin Kropff, MD, Robin Foà, John Catalano, MBBS FRACP FRCPA, Heinz Gisslinger, MD, Wieslaw Wiktor-Jedrzejczak, MD, PhD, Michel Delforge, MD, PhD, Katja Weisel, MD, Nicola Cascavilla, MD, Jan Van Droogenbroeck, Genadi Iosava, MD, Michele Cavo, MD, Joan Blade, Meral Beksac, MD, Ivan Spicka, MD, PhD, Torben Plesner, MD, Zhinuan Yu, Lindsey Herbein, Jay Mei, MD, PhD, Christian J. Jacques, Meletios Athanasios Dimopoulos, MD
Journal: Blood
Blood (2011) 118 (21): 475.
https://doi.org/10.1182/blood.V118.21.475.475
Published: 2011
Journal Articles

A Phase 3 Study Evaluating the Efficacy and Safety of Lenalidomide Combined with Melphalan and Prednisone In Patients ≥ 65 Years with Newly Diagnosed Multiple Myeloma (NDMM): Continuous Use of Lenalidomide Vs Fixed-Duration Regimens

Antonio Palumbo, MD, Michel Delforge, MD, PhD, John Catalano, MBBS, FRACP, FRCPA, Roman Hajek, MD, PhD, Martin Kropff, MD, Maria Teresa Petrucci, Zhinuan Yu, Lindsey Herbein, Jay M. Mei, MD, PhD, Christian J. Jacques, MD, Meletios A. Dimopoulos
Journal: Blood
Blood (2010) 116 (21): 622.
https://doi.org/10.1182/blood.V116.21.622.622
Published: 2010